These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11469616)

  • 1. Serum fructosamine as a screening test for type 2 diabetes.
    Klonoff DC
    Diabetes Technol Ther; 2000; 2(4):537-9. PubMed ID: 11469616
    [No Abstract]   [Full Text] [Related]  

  • 2. Pitfalls of glycated hemoglobin in the glycemic assessment of diabetes patients with hemoglobin louisville: role of serum fructosamine.
    Lorenzo-Medina M; de la Iglesia S; Ruiz-García L; Quintana-Hidalgo L; Martín-Alfaro R; Herrada J
    J Diabetes Sci Technol; 2013 May; 7(3):804-5. PubMed ID: 23759417
    [No Abstract]   [Full Text] [Related]  

  • 3. [CME laboratory tests. Diabetes mellitus].
    von Eckardstein A
    Praxis (Bern 1994); 2013 Mar; 102(6):357-61. PubMed ID: 23485760
    [No Abstract]   [Full Text] [Related]  

  • 4. Does measuring fructosamine help patients with diabetes?
    Edelman SV
    Eff Clin Pract; 2001; 4(4):189-90. PubMed ID: 11525109
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory testing in diabetes mellitus.
    Leroux M
    Adv Exp Med Biol; 2001; 498():359-66. PubMed ID: 11900391
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma fructosamine to evaluate metabolic control among women with gestational diabetes].
    Delgado M R; Novik A V; Cardemil M F; Santander A D
    Rev Med Chil; 2011 Nov; 139(11):1444-50. PubMed ID: 22446649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus.
    Mendes N; Tavares Ribeiro R; Serrano F
    J Obstet Gynaecol; 2018 Aug; 38(6):762-769. PubMed ID: 29620435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational diabetes: an evaluation of serum fructosamine as a screening test in a high-risk population.
    Agarwal MM; Dhatt GS; Othman Y; Ljubisavljevic MR
    Gynecol Obstet Invest; 2011; 71(3):207-12. PubMed ID: 21160150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum fructosamine vs glycohemoglobin as measures of glycemic control in a large diabetic population.
    Hom FG; Ettinger B; Lin MJ
    Acta Diabetol; 1998 Apr; 35(1):48-51. PubMed ID: 9625289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort.
    Malmström H; Walldius G; Grill V; Jungner I; Gudbjörnsdottir S; Hammar N
    PLoS One; 2014; 9(10):e111463. PubMed ID: 25353659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which screening test is the best for gestational impaired glucose tolerance and gestational diabetes mellitus?
    Tam WH; Rogers MS; Yip SK; Lau TK; Leung TY
    Diabetes Care; 2000 Sep; 23(9):1432. PubMed ID: 10977047
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetes and pregnancy].
    Schäfer-Graf U; Kleinwechter H
    MMW Fortschr Med; 2010 May; 152(18):37-40. PubMed ID: 20514762
    [No Abstract]   [Full Text] [Related]  

  • 13. Fructosamine and glycated hemoglobin in the assessment of glycaemic control in dogs.
    Loste A; Marca MC
    Vet Res; 2001; 32(1):55-62. PubMed ID: 11254177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructosamine as a screening-test for gestational diabetes mellitus: a reappraisal.
    Nasrat HA; Ajabnoor MA; Ardawi MS
    Int J Gynaecol Obstet; 1991 Jan; 34(1):27-33. PubMed ID: 1671017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between glycated haemoglobin, glycated albumin and fructosamine with neonatal birthweight and large-for-date status infants in gestational diabetes mellitus: a prospective cohort study.
    Mendes N; Alves M; Andrade R; Ribeiro RT; Papoila AL; Serrano F
    J Obstet Gynaecol; 2019 Aug; 39(6):768-773. PubMed ID: 31007102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
    Chon S; Lee YJ; Fraterrigo G; Pozzilli P; Choi MC; Kwon MK; Chin SO; Rhee SY; Oh S; Kim YS; Woo JT
    Diabetes Technol Ther; 2013 Jun; 15(6):455-60. PubMed ID: 23617251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated serum protein determination: comparison between thiobarbituric acid and fructosamine assays.
    Poli T; Lapolla A; Plebani M; Franchin A; Fedele D
    Acta Diabetol Lat; 1987; 24(3):241-7. PubMed ID: 3687316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the NZ guidelines for screening for persistent postpartum hyperglycaemia following gestational diabetes.
    Hughes RCE; Florkowski C; Gullam JE
    Aust N Z J Obstet Gynaecol; 2018 Aug; 58(4):432-437. PubMed ID: 29148563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
    Chan CL; Pyle L; Kelsey M; Newnes L; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.